Risk factors of low anterior resection syndrome after miniinvasive restorative rectal resection
Authors:
M. Macháčková 1; M. Škrovina 1; M. Szikhart 2; V. Benčurik 1; J. Bartoš 1; P. Anděl 1; H. Hlavíková 1; M. Dosoudil 1
Authors‘ workplace:
Chirurgické oddělení, Nemocnice AGEL, Nový Jičín
1; Stredná zdravotnícka škola, Záhradnícka ul., Bratislava
2
Published in:
Rozhl. Chir., 2021, roč. 100, č. 11, s. 552-558.
Category:
doi:
https://doi.org/10.33699/PIS.2021.100.11.552–558
Overview
Introduction: Over the last decades outcomes for rectal cancer surgery have improved with increasing survival and lower recurrence rates. Nevertheless, functional disorders are still frequent. Low anterior resection with total mesorectal excision (TME) in patients with rectal cancer has improved oncological outcomes. However, most of them will have significant changes in quality of life, including varying degree of bowel dysfunction. Aim of this study was to analyse prevalence of LARS (low anterior resection syndrome) in patients with rectal cancer after miniinvasive restorative resection and to define its risk factors.
Methods: Between March 2016 and June 2018, patients who underwent elective miniinvasive (laparoscopic or robotic) rectal resection were enrolled. Bowel dysfunction was evaluated by LARS questionnaire and filled out 6, 12, and 24 months after primary operation or after ileostomy closure. 98 patients completed the questionnaires – 58 laparoscopic operations, 34 robotic and 6 open procedures. 69 patients underwent TME, tumor-specific mesorectal excision 21 patients. 8 patients underwent transanal TME. The clinical characteristics, surgical perioperative and postoperative outcomes did not differ between these groups. Only, significantly more patients underwent neoadjuvant radiotherapy in the robotic group (p=0.004).
Results: 59.8% patients reported major LARS 6 months after surgery and 29.7% after 24 months. Protentional risk factors are age (p<0.05), tumor height (p<0.001), time from stoma resection (p<0.05), neoadjuvant (p<0.001) and adjuvant therapy (p<0.05).
Conclusion: Prevalence of LARS is high. It is underestimated, although an important factor. Radiotherapy and TME are significant risk factors of major LARS.
Keywords:
rectal cancer – risk factors – TME – LARS
Sources
1. Monson JR, Weiser MR, Buie WD, et al. Standards practice task force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2013 May;56(5):535−550. doi: 10.1097/DCR. 0b013e31828cb66c.
2. Peltrini R, Luglio G, Cassese G, et al. Oncological outcomes and quality of life after rectal cancer surgery. Open Med (Wars). 2019 Sep 12;14:653−662. doi: 10.1515/ med-2019-0075.
3. Sulkowski U, Mennigen R. Low anterior resection syndrome − diagnosis − therapy − prophylaxis. [Article in German] Zentralbl Chir. 2019 Aug;144(4):419−425. doi: 10.1055/a-0754-2482.
4. Ridolfi TJ, Berger N, Ludwig KA. Low anterior resection syndrome: Current management and future directions. Clin Colon Rectal Surg. 2016;29(3):239−245. doi:10.1055/s-0036-1584500.
5. Martellucci J. Low anterior resection syndrome: A treatment algorithm. Dis Colon Rectum. 2016 Jan;59(1):79−82. doi: 10.1097/DCR.0000000000000495
6. Kim MJ, Park JW, Lee MA, et al. Two dominant patterns of low anterior resection syndrome and their effects on patients‘ quality of life. Sci Rep. 2021 Feb 11;11(1):3538. doi: 10.1038/s41598-021- 82149-9.
7. Stelzner S, Kupsch J, Mees ST. Low anterior resection syndrome − causes and treatment approaches. [Article in German] Chirurg 2021 Apr 20. doi: 10.1007/ s00104-021-01398-6
8. Sarcher T, Dupont B, Alves A, et al. Anterior resection syndrome: What should we tell practitioners and patients in 2018? J Visc Surg. 2018 Oct;155(5):383−391. doi: 10.1016/j.jviscsurg.2018.03.006.
9. Keane C, Wells C, O‘Grady G, et al. Defining low anterior resection syndrome: a systematic review of the literature. Colorectal Dis. 2017 Aug;19(8):713−722. doi: 10.1111/codi.13767.
10. Emmertsen KJ, Laurberg S. Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg. 2012 May;255(5):922−928. doi: 10.1097/SLA.0b013e31824f1c21.
11. Battersby NJ, Bouliotis G, Emmertsen KJ, et al. UK and Danish LARS Study Groups. Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score. Gut. 2018 Apr;67(4):688−696. doi: 10.1136/gutjnl-2016-312695.
12. Keane C, Fearnhead NS, Bordeianou L, et al. LARS International Collaborative Group. International consensus definition of low anterior resection syndrome. Colorectal Dis. 2020 Mar;22(3):331−341. doi: 10.1111/codi.14957.
13. Kim CW, Jeong WK, Son GM, et al. Validation of Korean version of low anterior resection syndrome score questionnaire. Ann Coloproctol. 2020;36(2):83−87. doi:10.3393/ ac.2019.08.01
14. Bryant CL, Lunniss PJ, Knowles CH, et al. Anterior resection syndrome. Lancet Oncol. 2012 Sep;13(9):e403−408. doi: 10.1016/S1470-2045(12)70236-X.
15. Pieniowski EHA, Nordenvall C, Palmer G, et al. Prevalence of low anterior resection syndrome and impact on quality of life after rectal cancer surgery: population-based study. BJS Open. 2020 Oct;4(5):935−942. doi: 10.1002/ bjs5.50312.
16. Jimenez-Gomez LM, Espin-Basany E, Trenti L, et al. Factors associated with low anterior resection syndrome after surgical treatment of rectal cancer. Colorectal Dis. 2017 Sep 29. doi: 10.1111/ codi.13901.
17. Battersby NJ, Juul T, Christensen P, et al. United Kingdom Low Anterior Resection Syndrome Study Group. Predicting the risk of bowel-related quality- of-life impairment after restorative resection for rectal cancer: A multicenter cross-sectional study. Dis Colon Rectum 2016 Apr;59(4):270−280. doi: 10.1097/ DCR.0000000000000552.
18. Loos M, Quentmeier P, Schuster T, et al. Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013 Jun;20(6):1816−1828. doi: 10.1245/ s10434-012-2827-z.
19. Bregendahl S, Emmertsen KJ, Lous J, et al. Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population- based cross-sectional study. Colorectal Dis. 2013 Sep;15(9):1130−1139. doi: 10.1111/codi.12244.
20. Chen TY, Wiltink LM, Nout RA, et al. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clin Colorectal Cancer 2015 Jun;14(2):106−114. doi: 10.1016/j. clcc.2014.12.007.
21. Vogel I, Reeves N, Tanis PJ, et al. Impact of a defunctioning ileostomy and time to stoma closure on bowel function after low anterior resection for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2021 Apr 1. doi: 10.1007/s10151-021-02436-5.
22. Liu F, Guo P, Shen Z, et al. Risk factor analysis of low anterior resection syndrome after anal sphincter preserving surgery for rectal carcinoma. [Article in Chinese] Zhonghua Wei Chang Wai Ke Za Zhi 2017 Mar 25;20(3):289−294.
23. Lange MM, den Dulk M, Bossema ER, et al. Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial. Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg. 2007 Oct;94(10):1278−84. doi: 10.1002/ bjs.5819.
24. Park YY, Yang SY, Han YD, et al. Predictive factors for bowel dysfunction after sphincter-preserving surgery for rectal cancer: A single-center cross-sectional Study. Dis Colon Rectum 2019 Aug;62(8):925−933. doi: 10.1097/ DCR.0000000000001374.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2021 Issue 11
Most read in this issue
- Total mesorectal excision for rectal cancer – laparoscopic versus robotic approach
- Současné trendy v chirurgické léčbě karcinomu rekta
- TaTME (transanal total mesorectal excision) – state of the art
- Quality of life after transanal total mesorectal excision – our experience